PARABILIS MEDICINES INC

Parabilis Medicines (PBLS) hits USD 26.92, up 2.84% in 24 h – trading below its 200‑day average. See key metrics, peer performance and related biotech news.

Parabilis Medicines (PBLS) sees a modest 2.8% rise amid monthly 27% decline—explore why investors are watching its biotech outlook and upcoming earnings.

Parabilis Medicines (PBLS) jumps 6.82% amid market slump, trading above its 200‑day SMA yet still down 26.67% from last month—investors weigh cautious upside vs thin liquidity.